Sign in

CIK 0001382574 · Non-accelerated filer<br>Smaller reporting company

Scienture Holdings, Inc.

Sign in to watch
Ticker
SCNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 261 0281
Business address
20 AUSTIN BLVD., COMMACK, NY, 11725
Former names
TRxADE HEALTH, INC, TRXADE GROUP, INC., XCELLINK INTERNATIONAL INC., Bluebird Exploration Co.
  1. 4 Open-market sale Director sold 7,407 shares at an average $0.56 ($4,176)
  2. 4 Open-market sale Director sold 800 shares at $5.30 ($4,240)
  3. 4 Open-market sale President sold 7,500 shares at $5.29 ($39,703)
  4. 4 Open-market sale Director sold 500 shares at $5.30 ($2,650)
  5. 4 Open-market sale Director sold 1,800 shares at $5.26 ($9,460)
  6. 4 Open-market sale President sold 7,500 shares at an average $5.46 ($40,935)
  7. 4 Other disposition CEO disposed of 201,613 shares (other)
  8. 4 Grant or award President acquired 50,000 shares (grant or award)
  9. 4 Grant or award CEO acquired 123,504 shares (grant or award)
  10. 4 Grant or award Director acquired 8,987 shares (grant or award)
  11. 4 Grant or award Director acquired 8,987 shares (grant or award)
  12. 4 Grant or award Director acquired 8,987 shares (grant or award)
  13. 4 Grant or award CFO acquired 12,500 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 4 · 75 filings